Merck KGaA (MRK.DE)
-XETRA 119.00 
0.10(0.08%) May 17, 11:35AM EDT
| Prev Close: | 119.10 |
|---|
| Open: | 118.80 |
|---|
| Bid: | 118.90 |
|---|
| Ask: | 119.00 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 118.40 - 119.65 |
|---|
| 52wk Range: | 71.95 - 127.50 |
|---|
| Volume: | 372,601 |
|---|
| Avg Vol (3m): | 244,606 |
|---|
| Market Cap: | 25.87B |
|---|
| P/E (ttm): | 45.65 |
|---|
| EPS (ttm): | 2.61 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in EUR.
Headlines
- Merck KGaA Doesn’t Rule Out Pursuing Lung-Cancer Vaccineat Bloomberg(Fri, May 17)
- Oncothyreon slumps on new cancer drug dataAP(Thu, May 16)
- Merck KGAA Earnings Call scheduled for 8:00 am ET todayCCBN(Tue, May 14)
- Q1 2013 Merck KGaA Earnings Release - 01:00 am ETCCBN(Tue, May 14)
- Higher prices for MS drug help drug firm MerckAP(Tue, May 14)
- German Stocks Drop From Record on Sentiment Data, Chinaat Bloomberg(Tue, May 14)
- BRIEF-Merck shares rise after Q1 resultsat Reuters(Tue, May 14)
- Merck KGaA steps up cost savings, boosting profitat Reuters(Tue, May 14)
- Merck KGaA Profit Beats Estimates on Cost-Cuttingat Bloomberg(Tue, May 14)
- Merck KGaA Q1 adj operating profit jumps as trims costsat Reuters(Tue, May 14)
- China Is Hit With Five-Year EU Tariffs on Fittings, Tablewareat Bloomberg(Mon, May 13)
- Lufthansa Board Names Mayrhuber as Chairman After Back and Forthat Bloomberg(Tue, May 7)
- Lufthansa Board Stares Down Investors in Chairman Disputeat Bloomberg(Tue, May 7)
- Symphogen Raises $186 Million to Advance Cancer-Drug Pipelineat Bloomberg(Thu, May 2)
- BRIEF-Merck KGaA says restructuring costs totaled 500 million euros in 2012at Reuters(Fri, Apr 26)
Reports
- No Reports available for MRK.DE at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 2.32 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Merck KGaA operates as a pharmaceutical, chemical, and life science company worldwide. It operates through four divisions: Merck Serono, Consumer Health, Performance Materials, and Merck Millipore.
View More